Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Bio-Techne Corp - Common Stock
(NQ:
TECH
)
66.78
+0.92 (+1.40%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 6, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,547,126
Open
66.76
Bid (Size)
65.15 (100)
Ask (Size)
69.30 (100)
Prev. Close
65.86
Today's Range
65.84 - 67.60
52wk Range
46.01 - 77.03
Shares Outstanding
158,891,800
Dividend Yield
0.48%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
TECH Q4 Deep Dive: Margin Expansion and Flat Revenue Amid Mixed End Markets
February 05, 2026
Life sciences company Bio-Techne (NASDAQ:TECH) reported Q4 CY2025 results beating Wall Street’s revenue expectations, but sales were flat year on year at $295.9 million. Its non-GAAP profit of $0.46...
Via
StockStory
Wednesday's session: top gainers and losers in the S&P500 index
↗
February 04, 2026
Via
Chartmill
Performance
YTD
+12.0%
+12.0%
1 Month
+2.7%
+2.7%
3 Month
+16.3%
+16.3%
6 Month
+32.4%
+32.4%
1 Year
-11.0%
-11.0%
More News
Read More
Bio-Techne (TECH) Q2 2026 Earnings Call Transcript
↗
February 04, 2026
Via
The Motley Fool
Topics
Earnings
Bio-Techne Corp (NASDAQ:TECH) Reports Q2 Earnings Beat, Meets Revenue Forecasts
↗
February 04, 2026
Via
Chartmill
Topics
Earnings
Bio-Techne (NASDAQ:TECH) Surprises With Q4 CY2025 Sales
February 04, 2026
Via
StockStory
Bio-Techne (TECH) Reports Earnings Tomorrow: What To Expect
February 02, 2026
Via
StockStory
Topics
Artificial Intelligence
3 Unpopular Stocks That Concern Us
January 28, 2026
Via
StockStory
3 Cash-Producing Stocks That Fall Short
January 22, 2026
Via
StockStory
Picks and Shovels of the Bio-Revolution: A Deep Dive into Bio-Techne Corporation (TECH)
January 22, 2026
Via
Finterra
Topics
Regulatory Compliance
Supply Chain
1 High-Flying Stock for Long-Term Investors and 2 That Underwhelm
January 20, 2026
Via
StockStory
Movers and shakers in today's after-hours session for S&P500 stocks?
↗
January 19, 2026
Via
Chartmill
3 Small-Cap Stocks We Keep Off Our Radar
January 06, 2026
Via
StockStory
3 Reasons to Avoid TECH and 1 Stock to Buy Instead
January 05, 2026
Via
StockStory
Topics
Stocks
Supply Chain
1 S&P 500 Stock with Exciting Potential and 2 We Question
January 04, 2026
Via
StockStory
Topics
Stocks
Research Tools & Consumables Stocks Q3 Results: Benchmarking Bio-Techne (NASDAQ:TECH)
December 30, 2025
Via
StockStory
Topics
Economy
Bio-Techne Corp (NASDAQ:TECH) Passes the Caviar Cruise Screen for Quality Investors
↗
December 16, 2025
Via
Chartmill
3 High-Flying Stocks We Find Risky
December 01, 2025
Via
StockStory
Wall Street Holds Its Breath: Hopes for Fed Rate Cuts Fuel Volatility Amidst Economic Crossroads
December 04, 2025
Via
MarketMinute
Topics
Bonds
Economy
World Trade
3 Profitable Stocks with Questionable Fundamentals
December 01, 2025
Via
StockStory
Uncover the latest developments among S&P500 stocks in today's session.
↗
November 26, 2025
Via
Chartmill
Natera, GoodRx, and Bio-Techne Shares Are Soaring, What You Need To Know
November 24, 2025
Via
StockStory
Topics
Economy
Government
3 Healthcare Stocks We Steer Clear Of
November 24, 2025
Via
StockStory
Topics
Stocks
Envista, Alignment Healthcare, LifeStance Health Group, Avantor, and Bio-Techne Shares Are Soaring, What You Need To Know
November 21, 2025
Via
StockStory
Topics
Earnings
Economy
What's going on in today's session: S&P500 movers
↗
November 20, 2025
Via
Chartmill
Agilent Technologies (NYSE: A) Declares Quarterly Dividend, Signaling Continued Shareholder Value
November 19, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Regulatory Compliance
Frequently Asked Questions
Is Bio-Techne Corp - Common Stock publicly traded?
Yes, Bio-Techne Corp - Common Stock is publicly traded.
What exchange does Bio-Techne Corp - Common Stock trade on?
Bio-Techne Corp - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Bio-Techne Corp - Common Stock?
The ticker symbol for Bio-Techne Corp - Common Stock is TECH on the Nasdaq Stock Market
What is the current price of Bio-Techne Corp - Common Stock?
The current price of Bio-Techne Corp - Common Stock is 66.78
When was Bio-Techne Corp - Common Stock last traded?
The last trade of Bio-Techne Corp - Common Stock was at 02/06/26 04:00 PM ET
What is the market capitalization of Bio-Techne Corp - Common Stock?
The market capitalization of Bio-Techne Corp - Common Stock is 10.61B
How many shares of Bio-Techne Corp - Common Stock are outstanding?
Bio-Techne Corp - Common Stock has 11B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today